GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (OTCPK:POLBF) » Definitions » Total Stockholders Equity

POLBF (Poolbeg Pharma) Total Stockholders Equity : $15.84 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Poolbeg Pharma Total Stockholders Equity?

Poolbeg Pharma's Total Stockholders Equity for the quarter that ended in Jun. 2024 was $15.84 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Poolbeg Pharma's Book Value per Share for the quarter that ended in Jun. 2024 was $0.03. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Poolbeg Pharma's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.00.

Poolbeg Pharma Total Stockholders Equity Historical Data

The historical data trend for Poolbeg Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Total Stockholders Equity Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
30.03 22.32 18.28 11.72

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial 22.32 20.91 18.28 15.84 11.72

Poolbeg Pharma  (OTCPK:POLBF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Poolbeg Pharma's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(15.838-0)/500.000
=0.03

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Poolbeg Pharma's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 15.838
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poolbeg Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (OTCPK:POLBF) » Definitions » Total Stockholders Equity
Comparable Companies
LSE:AREC LSE:OPTI AQSE:PBX LSE:IMM LSE:IXI LSE:OBD LSE:SAR LSE:HEMO LSE:FAB AQSE:INC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
POLB:UK 7JN:Germany
Address
42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX
Website
https://www.poolbegpharma.com
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.